Latest news

• 4 December 2019

  FDA grants Orphan Drug Designation to APR Applied Pharma Research’s Investigational Drug for the Treatment of Epidermolysis Bullosa

  Balerna, 4th December 2019 – APR Applied Pharma Research sa...
• 28 November 2019

  3° trimestre 2019: industria farmaceutica ed energia guidano la crescita del PIL

  Berna, 28.11.2019 - Nel 3° trimestre 2019 il PIL svizzero,...
• 22 November 2019

  Helsinn Advanced Synthesis, Biasca: Reduces CO2 emissions by 80% and unveils the new anticancer plant

  - Sustainability and innovation at the heart of development...